Search
Search
In April 2025, the FDA and NIH released updated guidance on New Approach Methodologies (NAMs), signaling a clear move toward human-relevant, non-animal testing models in drug development. The aim is to make research more predictive, efficient, and better aligned with today’s safety standards. These updates also support the long-standing “3Rs” of research: Replace, Reduce, and Refine.
Thermo Fisher Scientific offers a broad portfolio of tools, media, and protocols to support your shift toward NAMs. Our technical teams and product solutions are designed to support the integration of new models into your workstreams, help generate high-quality data, and facilitate alignment with changing regulatory expectations.
This page will be updated regularly as new guidance, technologies, and resources become available.
Intended Use Statements may vary.